Renovorx Stock Filter Stocks by Fundamentals
| RNXT Stock | USD 1.50 0.09 6.38% |
RenovoRx fundamentals help investors to digest information that contributes to RenovoRx's financial success or failures. It also enables traders to predict the movement of RenovoRx Stock. The fundamental analysis module provides a way to measure RenovoRx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RenovoRx stock.
RenovoRx | Shares Owned by Insiders |
RenovoRx Current Valuation Drivers
We derive many important indicators used in calculating different scores of RenovoRx from analyzing RenovoRx's financial statements. These drivers represent accounts that assess RenovoRx's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of RenovoRx's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Enterprise Value | 63.9M | 28.0M | 14.8M | 22.4M | 25.8M | 44.5M |
RenovoRx Institutional Holders
Institutional Holdings refers to the ownership stake in RenovoRx that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of RenovoRx's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing RenovoRx's value.| Shares | Tower Research Capital Llc | 2024-09-30 | 4.1 K | Ubs Group Ag | 2024-09-30 | 2.2 K | Royal Bank Of Canada | 2024-06-30 | 203 | Bank Of America Corp | 2024-09-30 | 196 | Family Firm Inc | 2024-09-30 | 0.0 | Blackrock Inc | 2024-09-30 | 0.0 | Wells Fargo & Co | 2024-06-30 | 0.0 | Citadel Advisors Llc | 2024-09-30 | 0.0 | Renaissance Technologies Corp | 2024-09-30 | 0.0 | Bank Of Montreal | 2024-09-30 | 975 K | Bmo Capital Markets Corp. | 2024-09-30 | 975 K |
RenovoRx Fundamentals
| Return On Equity | -1.55 | ||||
| Return On Asset | -0.7 | ||||
| Current Valuation | 26.44 M | ||||
| Shares Outstanding | 24 M | ||||
| Shares Owned By Insiders | 1.90 % | ||||
| Shares Owned By Institutions | 8.18 % | ||||
| Number Of Shares Shorted | 115.53 K | ||||
| Price To Book | 5.09 X | ||||
| EBITDA | (11.39 M) | ||||
| Net Income | (10.23 M) | ||||
| Cash And Equivalents | 10.77 M | ||||
| Cash Per Share | 1.19 X | ||||
| Total Debt | 4.47 M | ||||
| Current Ratio | 10.01 X | ||||
| Book Value Per Share | (0.28) X | ||||
| Cash Flow From Operations | (10.26 M) | ||||
| Short Ratio | 3.43 X | ||||
| Earnings Per Share | (0.62) X | ||||
| Target Price | 5.5 | ||||
| Beta | 0.99 | ||||
| Market Capitalization | 36 M | ||||
| Total Asset | 1.47 M | ||||
| Retained Earnings | (41.41 M) | ||||
| Working Capital | 291 K | ||||
| Net Asset | 1.47 M |
About RenovoRx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RenovoRx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RenovoRx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RenovoRx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RenovoRx Stock Analysis
When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.